Peregrine Therapy, Pllc | |
16770 Ne 79th St Ste 105, Redmond, WA 98052-4413 | |
(425) 689-8570 | |
(425) 689-7521 |
Full Name | Peregrine Therapy, Pllc |
---|---|
Type | Facility |
Speciality | Clinic/center - Hearing And Speech |
Location | 16770 Ne 79th St Ste 105, Redmond, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003688540 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
261QH0700X | Clinic/center - Hearing And Speech | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Peregrine Therapy, Pllc 16770 Ne 79th St Ste 105, Redmond, WA 98052-4413 Ph: (425) 689-8570 | Peregrine Therapy, Pllc 16770 Ne 79th St Ste 105, Redmond, WA 98052-4413 Ph: (425) 689-8570 |
News Archive
Epitherix, LLC, a privately held company focused on the discovery and development of novel Wnt pathway small molecule inhibitors for epithelial and leukemic cancers, today announced that it has identified multiple chemical scaffolds that are potent and selective against colorectal carcinoma. "We're very encouraged by our in vitro and in vivo data, especially considering the difficulty in drugging this pathway to date," said Dr. Osman Kibar, CEO of Epitherix.
Some patients with advanced heart failure caused by cardiomyopathy, the deterioration of function of the heart muscle, are benefitting from a new recovery protocol at the University of Louisville and Jewish Hospital, a part of KentuckyOne Health.
The application of nanomaterials in the diagnosis, prevention, and treatment of viral diseases is reviewed in detail, highlighting areas of significant progress or stagnation from the past few decades.
In a world where global warming and long-distance travel quickly spread infectious diseases like COVID-19, innovative germ-killing coatings for hospitals could save lives
Stroke survivors who had ceased to benefit from conventional rehabilitation gained clinically significant arm movement and control by using an external robotic device powered by the patients' own brains.
› Verified 6 days ago